MedPath

Episiotomy wound n wound at perineal region

Phase 2/3
Recruiting
Conditions
patient having episiotomy wound
Registration Number
CTRI/2017/05/008524
Lead Sponsor
Parul Institute of Ayurved
Brief Summary

*Episiotomy is common procedure in obstetric practice. Incidence is 56% in india. There is scope to control pain and wound**healing**through ayurvedic medicine. Drug use in this study has properties like  wound healing, antiinflammatory and analgesic. By using standard scales assessment done.*

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • 1 Primipara patients who undergo vaginal delivery with episiotomy will be selected.
  • 2 Patient between ages 20 to 35 will be selected.
  • 3 No history of disease impaired wound healing.
  • 4 Those patient who ready to sign the inform consent form will be included only.
Exclusion Criteria
  • 1 Multipara.
  • 2 Patients with 3rd and 4th degree perineal tear or injury to rectum / urethra 3 Patients with any other major illnesses e.g. HIV, HbSAg, VDRL positive,cancer.
  • 4 Patients with history of delayed wound healing, IDDM, gestational diabetes, congenital bleeding disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Standardized REEDA Scale (Redness, Edema, Ecchymosed, Discharge and Approximation) and Numerical Rating Scale (NRS) (‘0-10’ point pain intensity scale)within 10 days outcome assessed
Secondary Outcome Measures
NameTimeMethod
Change in Standardized REEDA Scale (Redness, Edema, Ecchymosed, Discharge and Approximation) and Numerical Rating Scale (NRS) (‘0-10’ point pain intensity scale)within 10 days outcome assessed

Trial Locations

Locations (1)

PARUL AYURVED HOSPITAL

🇮🇳

Vadodara, GUJARAT, India

PARUL AYURVED HOSPITAL
🇮🇳Vadodara, GUJARAT, India
Trupti M Awagan
Principal investigator
07588879541
Awagantrupti@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.